Question 1

What is Elanco?

Accepted Answer

Elanco is a Company.

Question 2

How often does Elanco appear in global news?

Accepted Answer

Tracked across 3 news events drawn from 448 articles.

Question 3

When was Elanco first tracked by Ergen?

Accepted Answer

First tracked on Apr 13, 2026.

Question 4

When was Elanco last mentioned in news?

Accepted Answer

Last active on Jun 26, 2026.

Question 5

What is Elanco's current news sentiment?

Accepted Answer

Aggregate sentiment score: 10 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Elanco in global news coverage?

Accepted Answer

Attention score of 8, derived from article volume and coverage intensity across 3 events.

Question 7

What is the most recent event involving Elanco?

Accepted Answer

Zoetis Securities Fraud Class Actions (May 18, 2026, 251 articles).

Question 8

Who is Elanco most connected to?

Accepted Answer

Top relationships: Zoetis, Zoetis, United States — Food and Drug Administration.

Question 9

How did the "Zoetis Securities Fraud Class Actions" event impact Elanco?

Accepted Answer

Elanco is a competitor to Zoetis, with its products Credelio Quattro and Ilunocitinib gaining market share from Zoetis' key companion animal products.

Question 10

How did the "AI Stock Sell-off, Iran War" event impact Elanco?

Accepted Answer

Elanco rose 1.5% on expectations for stronger profits following the confirmation of the New World screwworm fly in south Texas.

Question 11

How did the "ImmuCell Appoints New Directors, Restructures Board" event impact Elanco?

Accepted Answer

Dr. Gilles Guillemette previously held executive positions at Elanco.

Question 12

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.